Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 15

1.

Circulating tumor cells as prognostic markers in neuroendocrine tumors.

Khan MS, Kirkwood A, Tsigani T, Garcia-Hernandez J, Hartley JA, Caplin ME, Meyer T.

J Clin Oncol. 2013 Jan 20;31(3):365-72. doi: 10.1200/JCO.2012.44.2905. Epub 2012 Dec 17.

PMID:
23248251
2.

Circulating tumor cells and prognosis of patients with resectable colorectal liver metastases or widespread metastatic colorectal cancer: a meta-analysis.

Groot Koerkamp B, Rahbari NN, Büchler MW, Koch M, Weitz J.

Ann Surg Oncol. 2013 Jul;20(7):2156-65. doi: 10.1245/s10434-013-2907-8. Epub 2013 Mar 2. Review.

PMID:
23456317
3.

CTCs in metastatic breast cancer.

Giordano A, Cristofanilli M.

Recent Results Cancer Res. 2012;195:193-201. doi: 10.1007/978-3-642-28160-0_18. Review.

PMID:
22527507
4.

Circulating cancer cells are potential weapon for future generations.

Dobrila-Dintinjana R.

Hepatogastroenterology. 2014 Jan-Feb;61(129):5-8. Review.

PMID:
24895783
5.

[Circulating tumor cells: liquid biopsy].

Alix-Panabières C, Pierga JY.

Bull Cancer. 2014 Jan 1;101(1):17-23. doi: 10.1684/bdc.2014.1883. Review. French.

PMID:
24445939
6.

Circulating and disseminated tumor cells in ovarian cancer: a systematic review.

Romero-Laorden N, Olmos D, Fehm T, Garcia-Donas J, Diaz-Padilla I.

Gynecol Oncol. 2014 Jun;133(3):632-9. doi: 10.1016/j.ygyno.2014.03.016. Epub 2014 Mar 19. Review.

PMID:
24657303
7.

Prognostic role of circulating tumor cells and disseminated tumor cells in patients with prostate cancer: a systematic review and meta-analysis.

Ma X, Xiao Z, Li X, Wang F, Zhang J, Zhou R, Wang J, Liu L.

Tumour Biol. 2014 Jun;35(6):5551-60. doi: 10.1007/s13277-014-1731-5. Epub 2014 Feb 22. Review.

PMID:
24563278
8.

Overview of current standpoints in profiling of circulating tumor cells.

Kim K, Lee KH, Lee J, Choi J.

Arch Pharm Res. 2014 Jan;37(1):88-95. doi: 10.1007/s12272-013-0285-1. Epub 2013 Nov 9. Review.

PMID:
24214218
9.

Diversity of assessing circulating tumor cells (CTCs) emphasizes need for standardization: a CTC Guide to design and report trials.

Bünger S, Zimmermann M, Habermann JK.

Cancer Metastasis Rev. 2015 Sep;34(3):527-45. doi: 10.1007/s10555-015-9582-0. Review.

PMID:
26323491
10.

Controversies in circulating tumor cell count during therapy.

Raimondi C, Gradilone A, Gazzaniga P.

Expert Rev Mol Diagn. 2013 Jun;13(5):499-507. doi: 10.1586/erm.13.33. Review.

PMID:
23782256
11.

Detection and isolation of circulating tumor cells: principles and methods.

Esmaeilsabzali H, Beischlag TV, Cox ME, Parameswaran AM, Park EJ.

Biotechnol Adv. 2013 Nov 15;31(7):1063-84. doi: 10.1016/j.biotechadv.2013.08.016. Epub 2013 Aug 30. Review.

PMID:
23999357
12.

Technologies for label-free separation of circulating tumor cells: from historical foundations to recent developments.

Jin C, McFaul SM, Duffy SP, Deng X, Tavassoli P, Black PC, Ma H.

Lab Chip. 2014 Jan 7;14(1):32-44. doi: 10.1039/c3lc50625h. Epub 2013 Aug 20. Review.

PMID:
23963515
13.

Neuroendocrine tumor biomarkers: From monoanalytes to transcripts and algorithms.

Modlin IM, Bodei L, Kidd M.

Best Pract Res Clin Endocrinol Metab. 2016 Jan;30(1):59-77. doi: 10.1016/j.beem.2016.01.002. Epub 2016 Jan 18. Review.

PMID:
26971844
14.

Microsystems for the capture of low-abundance cells.

Dharmasiri U, Witek MA, Adams AA, Soper SA.

Annu Rev Anal Chem (Palo Alto Calif). 2010;3:409-31. doi: 10.1146/annurev.anchem.111808.073610. Review.

PMID:
20636049
15.

Consensus on biomarkers for neuroendocrine tumour disease.

Oberg K, Modlin IM, De Herder W, Pavel M, Klimstra D, Frilling A, Metz DC, Heaney A, Kwekkeboom D, Strosberg J, Meyer T, Moss SF, Washington K, Wolin E, Liu E, Goldenring J.

Lancet Oncol. 2015 Sep;16(9):e435-46. doi: 10.1016/S1470-2045(15)00186-2. Review.

Supplemental Content

Support Center